Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 44 citing articles:

Understanding the Role of Histone Deacetylase and their Inhibitors in Neurodegenerative Disorders: Current Targets and Future Perspective
Vishal Kumar, Satyabrata Kundu, Arti Singh, et al.
Current Neuropharmacology (2021) Vol. 20, Iss. 1, pp. 158-178
Open Access | Times Cited: 119
Small molecule modulators of chromatin remodeling: from neurodevelopment to neurodegeneration
Dongfang Jiang, Tingting Li, Caixia Guo, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 31
Polyglutamine (PolyQ) Diseases: Navigating the Landscape of Neurodegeneration
Rumiana Tenchov, Janet M. Sasso, Qiongqiong Angela Zhou
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 15, pp. 2665-2694
Open Access | Times Cited: 11
The Effects of Pharmacological Inhibition of Histone Deacetylase 3 (HDAC3) in Huntington’s Disease Mice
Haiqun Jia, Ying Wang, Charles D. Morris, et al.
PLoS ONE (2016) Vol. 11, Iss. 3, pp. e0152498-e0152498
Open Access | Times Cited: 85
Complex neuroprotective and neurotoxic effects of histone deacetylases
Elizabeth A. Thomas, Santosh R. D’Mello
Journal of Neurochemistry (2018) Vol. 145, Iss. 2, pp. 96-110
Open Access | Times Cited: 66
HDAC3 is a potential validated target for cancer: An overview on the benzamide-based selective HDAC3 inhibitors through comparative SAR/QSAR/QAAR approaches
Nilanjan Adhikari, Sk. Abdul Amin, Prakruti Trivedi, et al.
European Journal of Medicinal Chemistry (2018) Vol. 157, pp. 1127-1142
Closed Access | Times Cited: 61
Dissecting Histone Deacetylase 3 in Multiple Disease Conditions: Selective Inhibition as a Promising Therapeutic Strategy
Nilanjan Adhikari, Tarun Jha, Balaram Ghosh
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 13, pp. 8827-8869
Closed Access | Times Cited: 44
Histone Deacetylase 3: A Potential Therapeutic Target for Atherosclerosis
Liping Jiang, Xiao-Hua Yu, Jin-Zhi Chen, et al.
Aging and Disease (2022) Vol. 13, Iss. 3, pp. 773-773
Open Access | Times Cited: 24
Upcoming Meetings Related to Huntington's Disease
Kelly E. Glajch, Ghazaleh Sadri‐Vakili
Journal of Huntington s Disease (2015) Vol. 4, Iss. 1, pp. 107-107
Open Access | Times Cited: 46
Histone Deacetylase Inhibitors: A Therapeutic Key in Neurological Disorders?
Małgorzata Ziemka‐Nałęcz, Joanna Jaworska, Joanna Sypecka, et al.
Journal of Neuropathology & Experimental Neurology (2018) Vol. 77, Iss. 10, pp. 855-870
Open Access | Times Cited: 44
Epigenetic Mechanisms Involved in Huntington's Disease Pathogenesis
Kelly E. Glajch, Ghazaleh Sadri‐Vakili
Journal of Huntington s Disease (2015) Vol. 4, Iss. 1, pp. 1-15
Open Access | Times Cited: 42
Class I and IIa Histone Deacetylases Have Opposite Effects on Sclerostin Gene Regulation
Stefan Baertschi, Nina Baur, Valerie Lueders-Lefevre, et al.
Journal of Biological Chemistry (2014) Vol. 289, Iss. 36, pp. 24995-25009
Open Access | Times Cited: 39
Sin3a regulates epithelial progenitor cell fate during lung development
Changfu Yao, Gianni Carraro, Bindu Konda, et al.
Development (2017) Vol. 144, Iss. 14, pp. 2618-2628
Open Access | Times Cited: 37
Cinnamamide Derivatives for Central and Peripheral Nervous System Disorders—A Review of Structure–Activity Relationships
Agnieszka Gunia‐Krzyżak, Katarzyna Pańczyk, Anna M. Waszkielewicz, et al.
ChemMedChem (2015) Vol. 10, Iss. 8, pp. 1302-1325
Closed Access | Times Cited: 36
High-throughput screening identifies histone deacetylase inhibitors that modulate GTF2I expression in 7q11.23 microduplication autism spectrum disorder patient-derived cortical neurons
Francesca Cavallo, Flavia Troglio, Giovanni Fagà, et al.
Molecular Autism (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 24
Clinical, Imaging, and Laboratory Markers of Premanifest Spinocerebellar Ataxia 1, 2, 3, and 6: A Systematic Review
Dong-Hoi Kim, Ryul Kim, Jee‐Young Lee, et al.
Journal of Clinical Neurology (2021) Vol. 17, Iss. 2, pp. 187-187
Open Access | Times Cited: 22
Fragment based G-QSAR and molecular dynamics based mechanistic simulations into hydroxamic-based HDAC inhibitors against spinocerebellar ataxia
Siddharth Sinha, Chetna Tyagi, Sukriti Goyal, et al.
Journal of Biomolecular Structure and Dynamics (2015) Vol. 34, Iss. 10, pp. 2281-2295
Open Access | Times Cited: 28
Histone deacetylases 1, 2 and 3 in nervous system development
Santosh R. D’Mello
Current Opinion in Pharmacology (2020) Vol. 50, pp. 74-81
Closed Access | Times Cited: 22
Histone deacetylase 3 indirectly modulates tubulin acetylation
Travis Bacon, Caroline Seiler, Marcin Wolny, et al.
Biochemical Journal (2015) Vol. 472, Iss. 3, pp. 367-377
Open Access | Times Cited: 22
The discovery of novel HDAC3 inhibitors via virtual screening and in vitro bioassay
Jie Xia, Huabin Hu, Wenjie Xue, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2018) Vol. 33, Iss. 1, pp. 525-535
Open Access | Times Cited: 21
New developments in Huntington’s disease and other triplet repeat diseases: DNA repair turns to the dark side
Robert S. Lahue
Neuronal Signaling (2020) Vol. 4, Iss. 4
Open Access | Times Cited: 20
The Bdnf and Npas4 genes are targets of HDAC3-mediated transcriptional repression
Anto Sam Crosslee Louis Sam Titus, Dharmendra Sharma, Min Soo Kim, et al.
BMC Neuroscience (2019) Vol. 20, Iss. 1
Open Access | Times Cited: 16
Histone deacetylase-3: Friend and foe of the brain
Santosh R. D’Mello
Experimental Biology and Medicine (2020) Vol. 245, Iss. 13, pp. 1130-1141
Open Access | Times Cited: 13
Proteomic analysis identifies NPTX1 and HIP1R as potential targets of histone deacetylase-3-mediated neurodegeneration
Zhe Qu, Santosh R. D’Mello
Experimental Biology and Medicine (2018) Vol. 243, Iss. 7, pp. 627-638
Open Access | Times Cited: 13
Plasticity of gene expression in the nervous system by exposure to environmental odorants that inhibit HDACs
Sachiko Haga‐Yamanaka, Rogelio Nunez-Flores, Christi Ann Scott, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top